newswire, breaking biotechnology and pharma news

Wednesday, November 17, 2010

Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) Identifies New Prospects for UV-400 Air Purifier With Rising Health Concerns Within Hospitality Market Segments

CENTERVILLE, MA � November 17, 2010 ( Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company"), announced today that the Company is expanding its focus within the Hospitality industry to newly identified areas suffering from serious health concerns for both customers and employees alike. Commencing immediately, the Company will direct efforts to provide its UV-400 air quality solution targeting the restaurant and spa sectors.
Restaurants generally prove vulnerable to poor indoor air quality, particularly with respect to the use of cleaning solvents in the dining room and bar areas, as well as the possibility for odors, mold and mildew that can plague food preparation areas.
In the personal grooming arena, Spas and Salons across the Country have demonstrated increasing evidence of illnesses affecting employees, customers, and even children due to the presence of Volatile Organic Compounds ("VOC") emitted by a variety of hair, nail and other personal grooming treatments, in many instances with little or no air purification whatsoever provided.
"There are serious ramifications building across the Country due to the lack of education on how damaging these contaminants are to the long term health of the people that are breathing them on a regular basis," said Jack Lennon, President of UV Flu Technologies. "We are contacted on a weekly basis by parents, as well as workers and customers, who have experienced symptoms of illness themselves, or whose children have experienced negative effects while certain treatments were underway with no air purification in evidence, or with non-functioning air purifiers being used."
"A particularly troubling aspect is that many of these individuals breathing these VOC's are at young ages critical to the development of their heart and lungs," continues Mr. Lennon, "Some of these popular hair treatments have been shown recently to contain up to 20% formaldehyde, while acetone and benzene are being used for nails. These contaminants are known carcinogens, and salons who are not addressing the concerns of their employees and customers are not only facing a loss of business, but the risk of litigation, as well as potential legislation."
Mr. Lennon continues, "Regarding the several-hundred thousand restaurants in this country, we believe that up to one in four restaurants suffers to a degree from odors caused by cleaning solvents, and in such a competitive marketplace it doesn't take much to adversely affect a business in an area that has already been severely hurt by the decline of the domestic economy. If people smell chemicals when they dine out, they may leave, or choose not to return... and in many instances it's a subliminal decision. In the food prep area there are many opportunities due principally to moisture that can affect the build-up of odors, mold and mildew. Good food preparation procedures alone can't prevent these types of air quality issues which ultimately could not only hurt the reputation of the business, but in extreme cases, cause its closure."
"Our air purifier, the ViraTech UV-400, reduces all types of odors and Volatile Organic Compounds, while also killing bacteria and other contaminants. The unit could potentially pay for itself in its first day of operation in many instances. We think from the standpoint of return on investment, as well an obligation to keep their employees and customers healthy and safe, this is a must-buy product," said Mr. Lennon.
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: For sales:
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
SOURCE: UV Flu Technologies, Inc.
UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on (please read disclosure and disclaimers)
Visit the showcase page on

Request info:

No comments:

Post a Comment